Table: Brightpath Biotherapeutics - Q1 parent results

BrightPath Biotherapeutics Co

13/08/2021 07:00

Aug 13 (Reuters)- 
             Brightpath Biotherapeutics Co., Ltd. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Jun 30, 2021        Jun 30, 2020      Mar 31, 2022  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             0 mln               0 mln             2 mln     
                 (-33.3 pct)         (-61.2 pct)       (-20.1 pct)  
  Operating     loss 402 mln        loss 408 mln        loss 1.85   
  Recurring     loss 403 mln        loss 407 mln        loss 1.85   
  Net           loss 402 mln        loss 409 mln        loss 1.85   
  EPS           loss 7.93 yen       loss 9.52 yen    loss 36.49 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T